QCR Holdings, Inc., a multi-bank holding company, provides commercial and consumer banking, and trust and asset management services. The company's deposit products include noninterest-bearing demand, interest-bearing demand, time, and brokered deposits. It also provides various commercial and retail lending/leasing, and investment services to corporations, partnerships, individuals, and government agencies. In addition, the company offers loans to small and mid-sized businesses; business loans, including lines of credit for working capital and operational purposes; term loans for the acquisition of facilities, equipment, and other purposes; commercial and residential real estate loans; and installment and other consumer loans, such as motor vehicle, home improvement, home equity, signature loans, and small personal credit lines, as well as issuance of trust preferred securities. QCR Holdings, Inc. was incorporated in 1993 and is headquartered in Moline, Illinois.…
QCR Holdings, Inc. Announces Agreement to Sell Three Branches to BankIowa
QCR Holdings (NASDAQ: QCRH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 1,016 employees.
The shares were at 96.79 USD on 20 November 2026, up 27.1% over 52 weeks. Its 52-week range is 74.78 USD to 107.88 USD: the price is 10.3% below the high and 29.4% above the low.
At a market capitalisation of 1.58B USD, it trades at 11.4 times trailing earnings and 10.7 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a premium of 11% for QCRH. It pays a dividend yielding 0.61% (it pays out 5% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
QCR Holdings reports return on equity of 11.4%, an operating margin of 43.7% and revenue down 2.5% year over year.
Its debt exceeds its cash by 736.74M USD, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 112.83 USD is 16.6% above the current price. The next earnings report is expected on 27 January 2027.